BRN.AX stock (BrainChip Holdings Ltd on the ASX) trades at A$0.15 in pre-market on 05 Feb 2026, down 3.23% from the previous close. Volume is elevated at 6,786,495 shares versus an average of 8,619,037, keeping liquidity reasonable for this small-cap AI play. Investors focus on Akida neuromorphic chips and upcoming catalysts, including the March earnings announcement and any new design wins that affect edge AI adoption.
Market snapshot for BRN.AX stock
BrainChip (BRN.AX) is priced at A$0.15 on the ASX with a market cap of A$353,768,742. Intraday range sits between A$0.15 and A$0.16, year high is A$0.33 and year low is A$0.15. Trading volume today is 6,786,495 shares, above the 50-day average price of A$0.17 and below the 200-day average of A$0.20.
Business model and catalysts for BRN.AX stock
BrainChip Holdings Ltd (BRN.AX) develops the Akida neuromorphic processor for ultra-low power edge AI in vision and audio applications. Key catalysts are new design wins in automotive and cybersecurity and any commercial shipments that convert lab wins into revenue. Positive newsflow on partnerships or mass-production contracts could lift sentiment and narrow valuation gaps with larger tech peers.
Financials and valuation of BRN.AX stock
Latest reported EPS is -0.02 and the trailing PE reads -7.50, reflecting losses. Price-to-sales and price-to-book ratios are elevated, with PB around 14.36, while the current ratio is 5.18, showing a strong short-term balance sheet. Revenue growth improved in FY 2024 by 71.55%, but free cash flow remains negative and investors should weigh growth against high valuation multiples.
Technicals and trading signals for BRN.AX stock
Momentum indicators show RSI at 60.30, CCI 137.05, and MFI 86.99, signalling short-term strength but potential overbought readings. Price sits near the lower Bollinger Band of A$0.15 to A$0.19 bands, and the 50-day average is A$0.17. Watch support at A$0.15 and resistance near A$0.17–A$0.20 for short-term trading setups.
Meyka AI grade and model forecast for BRN.AX stock
Meyka AI rates BRN.AX with a score of 64.90 out of 100 (B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly target of A$0.17, a monthly target of A$0.11, and a quarterly target of A$0.09. Compared with the current price of A$0.15, the model implies a +13.33% upside to A$0.17 and a -40.00% downside to A$0.09. Forecasts are model-based projections and not guarantees.
Investment outlook and risks for BRN.AX stock
BrainChip is an AI semiconductor specialist with upside linked to edge-AI adoption and commercial shipments. Upside scenarios include design wins and margin improvement from chip scaling. Key risks include continued negative earnings, high valuation multiples, and competition from established chipmakers. Monitor upcoming earnings on 04 Mar 2026 and any partner announcements that would materially change revenue visibility.
Final Thoughts
BRN.AX stock trades at A$0.15 in pre-market on 05 Feb 2026 with a mixed risk-reward profile for AI-focused investors. Our technicals show short-term strength but overbought momentum readings. Meyka AI’s forecast model projects a yearly price of A$0.17, implying about +13.33% upside from the current price, while the quarterly downside target at A$0.09 implies -40.00%. The proprietary Meyka grade of 64.90/100 (B, HOLD) reflects modest conviction: BrainChip has product-level promise but faces execution and valuation risk. For traders, watch support at A$0.15 and resistance at A$0.17–A$0.20. For longer-term AI investors, require demonstrable revenue traction or clear roadmap updates before increasing exposure. These views use Meyka AI-powered market analysis and do not constitute financial advice.
FAQs
What drives BRN.AX stock price moves?
BRN.AX stock moves on design wins, shipment announcements, and quarterly earnings. News on Akida chip adoption and partner contracts typically has the largest impact on short-term price and sentiment.
What is Meyka AI’s forecast for BRN.AX stock?
Meyka AI’s forecast model projects a yearly price of A$0.17, a monthly price of A$0.11 and a quarterly price of A$0.09. Models are projections and not guarantees.
Is BRN.AX stock a buy after the latest pre-market price?
At A$0.15, Meyka AI currently rates BRN.AX as B (HOLD). Investors should weigh growth prospects against negative EPS, high valuation multiples, and execution risk before buying.
When is BrainChip’s next earnings report that could affect BRN.AX stock?
BrainChip’s next earnings announcement is scheduled for 04 Mar 2026. That report is a key catalyst for revenue clarity and guidance that may move BRN.AX stock.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)